Skip to main content
. Author manuscript; available in PMC: 2014 Oct 29.
Published in final edited form as: Ann Clin Transl Neurol. 2014 Mar 29;1(5):307–318. doi: 10.1002/acn3.47

Figure 2. IL-33 expression in MS.

Figure 2

(a) Constitutive expression of IL-33 in MS, HC and OND patients in CD3+, CD14+ and CD19+ cells determined by intracellular cytokine staining and flow cytometry. Results are expressed as percent positive cells. Mean values are shown as horizontal bars, p<0.05 between MS and controls, for all subsets examined.

(b) As in (a) except PBMC were stimulated with LPS followed by intracellular cytokine staining to determine induced IL-33 expression in MS, HC and OND in CD14+ and CD19+ subsets of PBMC. Mean value are shown as horizontal bars, p<0.05 between MS and controls, for all subsets examined.

* The samples for these experiments were obtained from MS clinic at Vanderbilt.